CN100411672C - A medicinal composition for treatment of psoriasis - Google Patents
A medicinal composition for treatment of psoriasis Download PDFInfo
- Publication number
- CN100411672C CN100411672C CNB2006100966258A CN200610096625A CN100411672C CN 100411672 C CN100411672 C CN 100411672C CN B2006100966258 A CNB2006100966258 A CN B2006100966258A CN 200610096625 A CN200610096625 A CN 200610096625A CN 100411672 C CN100411672 C CN 100411672C
- Authority
- CN
- China
- Prior art keywords
- fructus
- radix
- pharmaceutical composition
- treatment
- poria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
A medical composition that cures for Psoriasis is described. It is characterized in that it is a kind of granular medicament including some raw material made by the following ratio of weight: Radix Codonopsis 10~30, Rhizoma Atractylodis Macrocephalae 1~5, Fructus Crataegi 10~30, Fructus Hordei Germinatus 1~5, Poria 1~5, Semen Raphani 1~5, Radix Glycyrrhizae 10~30, Radix et Rhizoma Salviae Miltiorrhizae 15~20, Fructus Schisandrae Chinensis 5~30. The medical composition in this invention has a reasonable compounding, a high degree of efficacy for any phase of Psoriasis and less poisonous side effect.
Description
Technical field
The present invention relates to a kind of is the pharmaceutical composition of raw material with the Chinese herbal medicine, the psoriatic pharmaceutical composition of particularly a kind of treatment.
Background technology
Psoriasis is " psoriasis " again, is a kind of common chronic inflammatory disease dermatoses, has the characteristics of intractable and recurrent, its skin lesion feature is to be covered with the silvery white squama of multilamellar on red pimple or the speckle, obvious seasonal is arranged, and most of patients state of an illness spring, winter increase the weight of, and alleviate summer.Whole nation total prevalence rate is 0.72 ‰, and the male is more than the women, and the north is more than south, and the city is higher than the rural area.Just send out an age male and be 20-39 year, the women is maximum for 15-39 year.Sickness rate is on the rise over past ten years.Think relevant with industrial pollution and working environment.
Though psoriasis does not directly influence life, but healthy and physical and mental health are had a direct impact.The main cause active oxygen of psoriasis is harmful product of body metabolism, is impregnated between blood cell in the matter, causes the human body environment pollution, the change of the pure matter of blood.Heat in blood, dry, the blood stasis of blood occur, accumulate stagnant resistance and too much cause pestilent toxicity to be sent out in skin.With the passing of time hematozemia wound essence is delayed in outbreak repeatedly all the year round, the course of disease, failure of skin and muscle to be nourished, and uninteresting pruritus, health is wrecked in the insomnia of overtaxing one's nerves.The delay recurrence increases the weight of year by year, and desquamation blood stasis, pruritus due to dryness bring great misery to body and mind unbearably!
The onset of psoriasis reason has many-sided theories such as heredity, immunologic function disorder, direct stimulation, trauma infection contamination at present, but does not still have clearly final conclusion; Doctor trained in Western medicine does not have specific short yet.At present many patients are because of arbitrarily abusing cell toxicant class antineoplastic agents such as aminopterin, ethyliminum, bimolane, cyclophosphamide, and hormone medicine treatments such as dexamethasone, prednisone, betamethasone and import injection triamcinolone, make body liver, kidney and immunologic function be subjected to more serious inhibition and damage.Part patient with after though certain short run effect is arranged, not long-time after the drug withdrawal, but the toxic and side effects that state of an illness knock-on increases the weight of to worsen appears; Many patients are deeply hurt.
Summary of the invention
Technical problem to be solved by this invention is at the deficiencies in the prior art, provides the treatment that a kind of compatibility is reasonable, side effect is little, therapeutic effect is good psoriatic pharmaceutical composition.
Technical problem to be solved by this invention is to realize by following technical scheme.The present invention is the psoriatic pharmaceutical composition of a kind of treatment, is characterized in, it is the medicament of being made by following materials of weight proportions medicine,
Radix Codonopsis 10-30 Rhizoma Atractylodis Macrocephalae 1-5 Fructus Crataegi (parched to brown) 10-30
Fructus Hordei Germinatus 1-5 Poria 1-5 Semen Raphani 1-5
Radix Glycyrrhizae 10-30 Radix Salviae Miltiorrhizae 15-20 Fructus Schisandrae Chinensis 5-30.
Technical problem to be solved by this invention can also further realize by following technical scheme.The psoriatic pharmaceutical composition of above-described a kind of treatment is characterized in, the weight proportion of each crude drug is,
Radix Codonopsis 15 Rhizoma Atractylodis Macrocephalaes 3 Fructus Crataegi (parched to brown)s 15
Fructus Hordei Germinatus 3 Poria 3 Semen Raphanis 3
Radix Glycyrrhizae 15 Radix Salviae Miltiorrhizaes 20 Fructus Schisandrae Chinensis 15.
Pharmaceutical composition of the present invention can be made the medicament of any dosage form of acceptable clinically, preferred particulates agent, pill, capsule, tablet.
Technical problem to be solved by this invention can also further realize by following technical scheme.The psoriatic pharmaceutical composition of above-described a kind of treatment is characterized in, the preparation method of described pill is, takes by weighing each crude drug in proportion, and mixed powder is broken into fine powder, crosses the 150-200 mesh sieve, adds Mel and makes honeyed pill, promptly.
Below be that the inventor does the psoriatic clinical experiment effect of the medicine composite for curing of the present invention data of using.
One, medicine.By inventor's self-control, make Radix Codonopsis 15, the Rhizoma Atractylodis Macrocephalae 3, Fructus Crataegi (parched to brown) 15, Fructus Hordei Germinatus 3, Poria 3, Semen Raphani 3, Radix Glycyrrhizae 15, Radix Salviae Miltiorrhizae 20, Fructus Schisandrae Chinensis 15 by following weight proportion.Its preparation method is, takes by weighing each crude drug in proportion, and mixed powder is broken into fine powder, crosses the 150-200 mesh sieve, adds Mel and makes honeyed pill, and every ball contains crude drug fine powder 3-5 gram.
Two, the using method of medicine is: pills, every day 2-3 time, about each 10 grams, children's reduces by half, and 1 month is a course of treatment, divides disease the lighter and seriously ill person by sick time length, sick the lighter's sick time is below 5 years, seriously ill person's sick time is more than 5 years, and sick the lighter takes 2-4 the course of treatment, and seriously ill person takes 4-6 the course of treatment.
Three, the present invention has curative effect preferably through clinical use, now is described as follows:
1, psoriatic's situation explanation.
Sick the lighter: total 49 examples, wherein: male 21 examples, 10-25 year 9 examples, 25-50 year 12 examples; Woman's 28 examples, 10-25 year 11 examples, 25-50 year 17 examples.
Seriously ill person: total 41 examples, wherein: male 29 examples, 10-25 year 9 examples, 25-50 year 20 examples; Woman's 12 examples, 10-25 year 4 examples, 25-50 year 8 examples.
2, curative effect judging standard.
Recovery from illness: skin lesion all disappear (or leave over be no more than 10%);
Produce effects: skin lesion disappears 50%～90%;
Invalid: skin lesion does not reduce;
Recovery from illness+produce effects is a total effective rate.
2, clinical treatment result.
Compared with prior art, drug regimen composition formula of the present invention is reasonable, evident in efficacy, and toxic and side effects is little, and each psoriasis pustulosa of each phase is all had significant curative effect, and anti-recurrence is strong.
The specific embodiment
Embodiment 1.The psoriatic pharmaceutical composition of a kind of treatment, it is the granule of being made by following materials of weight proportions medicine,
Radix Codonopsis 10 Rhizoma Atractylodis Macrocephalaes 1 Fructus Crataegi (parched to brown) 10
Fructus Hordei Germinatus 1 Poria 1 Semen Raphani 1
Radix Glycyrrhizae 10 Radix Salviae Miltiorrhizaes 15 Fructus Schisandrae Chinensis 5.
Its preparation method is that technology extracts the active ingredient of each crude drug routinely, adds pharmaceutic adjuvant, makes granule.
Embodiment 2.The psoriatic pharmaceutical composition of a kind of treatment, it is the tablet of being made by following materials of weight proportions medicine,
Radix Codonopsis 30 Rhizoma Atractylodis Macrocephalaes 5 Fructus Crataegi (parched to brown)s 30
Fructus Hordei Germinatus 5 Poria 5 Semen Raphanis 5
Radix Glycyrrhizae 30 Radix Salviae Miltiorrhizaes 20 Fructus Schisandrae Chinensis 30.
Its preparation method is that technology extracts the active ingredient of each crude drug routinely, adds pharmaceutic adjuvant, makes tablet.
Embodiment 3.The psoriatic pharmaceutical composition of a kind of treatment, it is the pill of being made by following materials of weight proportions medicine,
Radix Codonopsis 20 Rhizoma Atractylodis Macrocephalaes 2 Fructus Crataegi (parched to brown)s 20
Fructus Hordei Germinatus 2 Poria 2 Semen Raphanis 2
Radix Glycyrrhizae 20 Radix Salviae Miltiorrhizaes 18 Fructus Schisandrae Chinensis 20.
Its preparation method is that technology extracts the active ingredient of each crude drug routinely, adds pharmaceutic adjuvant, makes pill.
Embodiment 4.The psoriatic pharmaceutical composition of a kind of treatment, it is the capsule of being made by following materials of weight proportions medicine,
Radix Codonopsis 18 Rhizoma Atractylodis Macrocephalaes 4 Fructus Crataegi (parched to brown)s 18
Fructus Hordei Germinatus 4 Poria 4 Semen Raphanis 4
Radix Glycyrrhizae 18 Radix Salviae Miltiorrhizaes 16 Fructus Schisandrae Chinensis 10.
Its preparation method is that technology extracts the active ingredient of each crude drug routinely, adds pharmaceutic adjuvant, makes capsule.
Embodiment 5.The psoriatic pharmaceutical composition of a kind of treatment, it is the oral liquid of being made by following materials of weight proportions medicine,
Radix Codonopsis 25 Rhizoma Atractylodis Macrocephalaes 2 Fructus Crataegi (parched to brown)s 25
Fructus Hordei Germinatus 2 Poria 2 Semen Raphanis 2
Radix Glycyrrhizae 25 Radix Salviae Miltiorrhizaes 17 Fructus Schisandrae Chinensis 25.
Its preparation method is that technology extracts the active ingredient of each crude drug routinely, adds pharmaceutic adjuvant, makes oral liquid.
Embodiment 6.The psoriatic pharmaceutical composition of a kind of treatment, it is the pill of being made by following materials of weight proportions medicine,
Radix Codonopsis 15 Rhizoma Atractylodis Macrocephalaes 3 Fructus Crataegi (parched to brown)s 15
Fructus Hordei Germinatus 3 Poria 3 Semen Raphanis 3
Radix Glycyrrhizae 15 Radix Salviae Miltiorrhizaes 20 Fructus Schisandrae Chinensis 15.
The preparation method of described pill is, takes by weighing each crude drug in proportion, and mixed powder is broken into fine powder, crosses the 150-200 mesh sieve, adds Mel and makes honeyed pill, promptly.
Claims (4)
1. the psoriatic pharmaceutical composition of treatment is characterized in that it is the medicament of being made by following materials of weight proportions medicine,
Radix Codonopsis 10-30 Rhizoma Atractylodis Macrocephalae 1-5 Fructus Crataegi (parched to brown) 10-30
Fructus Hordei Germinatus 1-5 Poria 1-5 Semen Raphani 1-5
Radix Glycyrrhizae 10-30 Radix Salviae Miltiorrhizae 15-20 Fructus Schisandrae Chinensis 5-30.
2. the psoriatic pharmaceutical composition of a kind of treatment according to claim 1 is characterized in that, the weight proportion of each crude drug is,
Radix Codonopsis 15 Rhizoma Atractylodis Macrocephalaes 3 Fructus Crataegi (parched to brown)s 15
Fructus Hordei Germinatus 3 Poria 3 Semen Raphanis 3
Radix Glycyrrhizae 15 Radix Salviae Miltiorrhizaes 20 Fructus Schisandrae Chinensis 15.
3. the psoriatic pharmaceutical composition of a kind of treatment according to claim 1 is characterized in that described medicament is granule, pill, capsule, tablet.
4. the psoriatic pharmaceutical composition of a kind of treatment according to claim 3 is characterized in that, the preparation method of described pill is, takes by weighing each crude drug in proportion, and mixed powder is broken into fine powder, crosses the 150-200 mesh sieve, adds Mel and makes honeyed pill, promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100966258A CN100411672C (en) | 2006-10-12 | 2006-10-12 | A medicinal composition for treatment of psoriasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100966258A CN100411672C (en) | 2006-10-12 | 2006-10-12 | A medicinal composition for treatment of psoriasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1943732A CN1943732A (en) | 2007-04-11 |
| CN100411672C true CN100411672C (en) | 2008-08-20 |
Family
ID=38043526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100966258A Expired - Fee Related CN100411672C (en) | 2006-10-12 | 2006-10-12 | A medicinal composition for treatment of psoriasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100411672C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104288618B (en) * | 2014-10-16 | 2017-07-21 | 史飞 | A kind of Chinese medicine composition for treating children's psoriasis vulgaris |
| CN108030903A (en) * | 2017-12-14 | 2018-05-15 | 珠海横琴新区德群中医药科学研究院有限公司 | One kind is used to treat psoriasic Chinese medicine |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1562324A (en) * | 2004-04-16 | 2005-01-12 | 李有凤 | External remedy for curing eczema |
-
2006
- 2006-10-12 CN CNB2006100966258A patent/CN100411672C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1562324A (en) * | 2004-04-16 | 2005-01-12 | 李有凤 | External remedy for curing eczema |
Non-Patent Citations (4)
| Title |
|---|
| 浅谈中医治疗牛皮癣. 皮德艳.中国科技信息，第12期. 2005 |
| 浅谈中医治疗牛皮癣. 皮德艳.中国科技信息，第12期. 2005 * |
| 蜂产品中黄酮类化合物的保健作用. 郭芳彬.养蜂科技，第2期. 2005 |
| 蜂产品中黄酮类化合物的保健作用. 郭芳彬.养蜂科技，第2期. 2005 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1943732A (en) | 2007-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1061854C (en) | Medicinal preparation for treatment and prevention of gynopathy | |
| CN100563690C (en) | A kind of medicine for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and disease of proplapse of lumbar intervertebral disc | |
| CN102258658A (en) | Plaster for invigorating blood circulation and relieving pain | |
| CN102133271B (en) | Medicinal tea for curing gout | |
| CN100460008C (en) | Chinese medicine composition for treating cancer | |
| KR20240102982A (en) | Traditional Chinese herbal medicine for the treatment of hives, eczema, allergies/kinetic reactive constitution | |
| CN102580000B (en) | Medicament for curing cancer pain and preparation method thereof | |
| CN1305515C (en) | Chinese medicinal powder and decoction composition for treating cancer | |
| CN118105451A (en) | Medicinal and edible composition for preventing and treating ulcerative colitis and application thereof | |
| CN100411672C (en) | A medicinal composition for treatment of psoriasis | |
| CN101214365B (en) | Chinese medicine composing prescription for treating mastoproliferation | |
| CN103599455B (en) | Traditional Chinese medicine capsule for removing freckle | |
| CN101804189A (en) | Drug for treating primary dysmenorrhea | |
| CN103191399A (en) | Traditional Chinese medicine composition for treating bronchial asthma in acute-outbreak period | |
| CN114028507A (en) | Preparation method of traditional Chinese medicine for treating lumbago | |
| CN103495130B (en) | Traditional Chinese medicine composition for treating asthma | |
| CN1253196C (en) | Medicine for treating colitis | |
| CN112618626A (en) | Traditional Chinese medicine spray for treating herpes zoster and preparation method thereof | |
| CN104288597A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN104306847A (en) | Six-ingredient qi-tonifying capsule and preparation process thereof | |
| CN103585471B (en) | Traditional Chinese medicine composition for treating thrombocytopenia | |
| CN101129983A (en) | Chaihuang Qingdan Wan (Chaihuang Bolus for clearing gallbladder) | |
| CN102861292A (en) | Medicament for treating esophageal cancer and preparation method thereof | |
| CN101032613B (en) | Hepatic cyst-treating Chinese traditional medicine preparation and its preparation process | |
| CN1813876A (en) | Xian Pengliaofu oral preparation-a Chinese medicine for treating bone disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080820 Termination date: 20131012 |